NCT02362308View on ClinicalTrials.gov

Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Primary Aldosteronism
Interventions
OTHER

Adrenalectomy

Adrenalectomy for treatment of primary aldosteronism, according to standard of care

DRUG

mineralocorticoid receptor antagonist

Subjects will be treated with a mineralocorticoid receptor antagonist according to standard of care

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Vanderbilt University

OTHER

NCT02362308 - Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas | Biotech Hunter | Biotech Hunter